Home » Stocks » SNOA

Sonoma Pharmaceuticals, Inc. (SNOA)

Stock Price: $7.16 USD 0.35 (5.14%)
Updated Mar 5, 2021 3:59 PM EST - Market closed
After-hours: $7.15 -0.01 (-0.14%) Mar 5, 4:00 PM
Market Cap 14.05M
Revenue (ttm) 21.05M
Net Income (ttm) -1.66M
Shares Out 2.05M
EPS (ttm) -0.87
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 5
Last Price $7.16
Previous Close $6.81
Change ($) 0.35
Change (%) 5.14%
Day's Open 6.78
Day's Range 6.65 - 7.30
Day's Volume 47,927
52-Week Range 3.55 - 19.60

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 day ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range ...

Newsfile Corp - 2 weeks ago

New York, New York--(Newsfile Corp. - February 19, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholder...

Business Wire - 2 weeks ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range ...

GlobeNewsWire - 2 weeks ago

NEW YORK, Feb. 15, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pha...

Newsfile Corp - 3 weeks ago

Los Angeles, California--(Newsfile Corp. - February 8, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inves...

PRNewsWire - 1 month ago

LOS ANGELES, Feb. 1, 2021 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sonoma Pharmac...

Business Wire - 1 month ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range ...

PRNewsWire - 1 month ago

NEW YORK, Jan. 18, 2021 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceutic...

Business Wire - 1 month ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range ...

Business Wire - 2 months ago

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc. (NA...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. (“Sonoma” or the “Company”) (NASDAQ: SNOA).   Such inve...

Benzinga - 2 months ago

Sonoma Pharmaceuticals (NASDAQ: SNOA) shares are trading higher on Friday after the company announced a partnership with Gabriel Science for dental markets. Sonoma is engaged in identifying, d...

Other stocks mentioned: DARE, MDNAF
Business Wire - 2 months ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals and Gabriel Science enter into distribution agreement for the sale of HOCl-products into the dental markets.

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 16, 2020) - Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. ("Sonoma" or the "Company") (NASDAQ: SNO...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. (“Sonoma” or the “Company”) (NASDAQ: SNOA).   Such inve...

InvestorPlace - 2 months ago

Sonoma Pharmaceuticals (SNOA) is in the news Friday after announcing a deal with Crown Laboratories that has SNOA stock on the rise. The post Sonoma Pharmaceuticals News Alert: Why SNOA Stock ...

Business Wire - 2 months ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals and Crown Laboratories announce an exclusive partnership to launch Microcyn® Technology-based anti-itch OTC products.

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - December 8, 2020) - Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholder...

GlobeNewsWire - 2 months ago

NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. (“Sonoma” or the “Company”) (NASDAQ: SNOA).   Such inve...

GlobeNewsWire - 3 months ago

NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. (“Sonoma” or the “Company”) (NASDAQ: SNOA). Such invest...

Business Wire - 3 months ago

LOS ANGELES--(BUSINESS WIRE)---- $SNOA #SNOA--ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc.

PRNewsWire - 3 months ago

NEW YORK, Nov. 25, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sonoma Pharmaceuticals, Inc. ("Sonoma" or the "Company") (NASDAQ: SNOA). Such investors ...

GlobeNewsWire - 3 months ago

Investors can contact the law firm at no cost to learn more about recovering their losses Investors can contact the law firm at no cost to learn more about recovering their losses

Newsfile Corp - 3 months ago

Los Angeles, California--(Newsfile Corp. - November 25, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of inve...

PRNewsWire - 3 months ago

NEW YORK, Nov. 24, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Sonoma Pharmaceutic...

Business Wire - 3 months ago

LOS ANGELES--(BUSINESS WIRE)---- $SNOA #SNOA--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sonoma Pharmaceuticals, Inc.

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - November 24, 2020) - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of ...

Business Wire - 3 months ago

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Sonoma Pharmaceuticals, Inc...

Business Wire - 3 months ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range ...

GuruFocus - 4 months ago

The Covid-19 pandemic has given a significant boost to many industries such as manufacturers of gloves, masks, sanitizers, PPE (personal protective equipment), health insurance providers, and ...

Other stocks mentioned: CLX, CMD, ECL, KMB, NEOG
Business Wire - 5 months ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc.

Business Wire - 5 months ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc.

Business Wire - 6 months ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc.

InvestorPlace - 7 months ago

Sonoma Pharmaceuticals (SNOA) is in the news Wednesday after an update concerning its Microsafe disinfectant sent SNOA stock soaring. The post Sonoma Pharmaceuticals News: Why SNOA Stock Is Sk...

Business Wire - 7 months ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc.

Business Wire - 7 months ago

WOODSTOCK, Ga.--(BUSINESS WIRE)--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range ...

Benzinga - 9 months ago

Sonoma Pharmaceuticals (NASDAQ: SNOA) shares are trading higher on Friday. The company announced that its Nanocyn Disinfectant & Sanitizer has received approval to be entered into the Australi...

InvestorPlace - 9 months ago

Sonoma Pharmaceuticals (SNOA) is in the news Friday after approval for a disinfectant of the novel coronavirus sent SNOA stock skyrocketing. The post Sonoma Pharmaceuticals News: SNOA Stock Sk...

Market Watch - 9 months ago

Shares of Sonoma Pharmaceuticals Inc. SNOA, +216.63% nearly tripled on heavy volume in premarket trading Friday

GlobeNewsWire - 1 year ago

PETALUMA, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company dedicated to identifying, developing and commercializing u...

GlobeNewsWire - 1 year ago

PETALUMA, Calif., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a specialty pharmaceutical company dedicated to identifying, developing and commercializing u...

GlobeNewsWire - 1 year ago

PETALUMA, Calif., Nov. 29, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the closing of a public offering of 446,577 shares of common stock at a public...

GlobeNewsWire - 1 year ago

PETALUMA, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the pricing of its previously announced “best efforts” public offering of shar...

GlobeNewsWire - 1 year ago

PETALUMA, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the launch of a “best efforts” public offering of shares of its common stock.

GlobeNewsWire - 1 year ago

Agreement with CEO and Interim CFO Bubba Sandford ends Amy Trombly Appointed as Interim CEO John Dal Poggetto Appointed as New CFO

About SNOA

Sonoma Pharmaceuticals, develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, a hypochlorous acid (HOCl) based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a product indicated to promote healing through the management of n... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Jan 25, 2007
CEO
Amy Trombly
Employees
19
Stock Exchange
NASDAQ
Ticker Symbol
SNOA
Full Company Profile

Financial Performance

In 2019, SNOA's revenue was $18.94 million, a decrease of -0.18% compared to the previous year's $18.97 million. Losses were -$2.95 million, -75.03% less than in 2018.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for SNOA is 9.00, which is an increase of 25.70% from the latest price.

Price Target
$9.00
(25.70% upside)